Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RYZ101
i
Other names:
RYZ101, Actinium 225 radiolabeled somatostatin analog, 225Ac-DOTATATE, Actinium-225 DOTATATE
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
RayzeBio
Drug class:
α radiation emission, Somatostatin inhibitor
Related drugs:
‹
Ac-225 ErbB3 targeted radiotherapy (4)
lintuzumab-Ac225 (2)
ORM-2110 (1)
pasireotide (1)
Ac-225 ErbB3 targeted radiotherapy (4)
lintuzumab-Ac225 (2)
ORM-2110 (1)
pasireotide (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
SSTR2 overexpression
Small Cell Lung Cancer
SSTR2 overexpression
Small Cell Lung Cancer
RYZ101
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
RYZ101
Sensitive
:
D
AACR 2023 - 1wk
RYZ101
Sensitive: D – Preclinical
AACR 2023 - 1 week
RYZ101
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login